Published in Z Arztl Fortbild (Jena) on September 15, 1972
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group. Leukemia (1998) 1.44
E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer (2009) 1.12
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol (1999) 1.08
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. Br J Haematol (2001) 1.02
[Secondary synovial chondromatosis of the ankle joint]. Orthopade (2011) 1.01
Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys (2001) 0.95
As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout. Rheumatol Int (2013) 0.90
[Drug-induced exudative erythema multiforme major with a chronic progressive course and bilateral blindness. Clinical and immunohistologic follow-up]. Klin Monbl Augenheilkd (1990) 0.86
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. Klin Padiatr (2004) 0.83
Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis. J Clin Oncol (2001) 0.82
[Development of a specialised paediatric palliative home care service]. Klin Padiatr (2009) 0.79
[Studies of enterotoxin production by strains of Staphylococcus aureus of different origins (author's transl)]. Zentralbl Bakteriol Orig A (1976) 0.79
[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]. Klin Padiatr (1994) 0.79
Computed tomography-guided transtracheal needle aspiration of paratracheal lymphadenopathy in endoscopically normal patients. Invest Radiol (1997) 0.79
Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies. Klin Padiatr (2003) 0.79
[Pulmonary blastoma in childhood--a case report and review of the literature]. Z Kinderchir (1987) 0.79
[EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results]. Klin Padiatr (1999) 0.78
Auxin-induced H(+)-pump stimulation does not depend on the presence of epidermal cells in corn coleoptiles. Planta (1992) 0.78
[Measurement methods for self-assessment of the state of health by rheumatism patients]. Z Rheumatol (1984) 0.77
A study of Campylobacter jejuni and Campylobacter coli in a river system. Zentralbl Hyg Umweltmed (1989) 0.77
[Clinical types of immunologic transplant reactions following perforating keratoplasty]. Fortschr Ophthalmol (1990) 0.76
Threshold of hearing by bone conduction. A contribution to international standardization. Scand Audiol (1981) 0.76
[Out-patient palliative care of children with cancer and their families]. Klin Padiatr (2004) 0.76
Development of the rabbit retina, III: Differential retinal growth, and density of projection neurons and interneurons. Vis Neurosci (1993) 0.76
Purification, characterisation and cDNA sequencing of pyruvate decarboxylase from Zygosaccharomyces bisporus. Biol Chem (2000) 0.76
Final height and puberty in 40 patients after antileukaemic treatment during childhood. Eur J Pediatr (1997) 0.76
[18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations]. Klin Padiatr (2003) 0.75
[The sensitivity of B. pertussis to antibiotics. Examination of 122 patients' strains of B. pertussis]. Z Kinderheilkd (1969) 0.75
[Varicellas and herpes zoster in children with oncologic diseases. 1: Clinical characteristics]. Z Arztl Fortbild (Jena) (1989) 0.75
[C-reactive protein, Il-6 and procalcitonin as infection parameters in children with oncologic diseases]. Klin Padiatr (2001) 0.75
[Disturbances of the complement system in renal failure and the influence of amino acid substitution (author's transl)]. Dtsch Med Wochenschr (1974) 0.75
[Hickman catheter for long-term parenteral therapy. A prospective interdisciplinary study]. Med Klin (Munich) (1992) 0.75
[Treatment of recurrence in children with acute lymphoblastic leukemias]. Padiatr Grenzgeb (1983) 0.75
Influence of temperature on the output of a mechanical coupler. Ear Hear (1985) 0.75
[Preventability of the OPSI syndrome?]. Padiatr Grenzgeb (1986) 0.75
[Vertical and sagittal relapse following surgical-orthodontic correction of distal bite position. Cephalometric longitudinal study]. Inf Orthod Kieferorthop (1990) 0.75
Transcatheter endomyocardial laser revascularization: a feasibility test. Thorac Cardiovasc Surg (1998) 0.75
[Animal experiment studies on the kidney affinity and variability in renal tissue of 20 Staphylococcus aureus strains]. Z Gesamte Hyg (1975) 0.75
[Epidemiology and epizootiology of enteritis caused by Campylobacter jejuni and Campylobacter coli]. Pol Tyg Lek (1986) 0.75
[Recommendations for the diagnosis and therapy of inflammatory diseases of the central nervous system in children]. Z Arztl Fortbild (Jena) (1974) 0.75
[Experience with 131I-MIBG scintigraphy of children with neuroblastoma]. Radiobiol Radiother (Berl) (1987) 0.75
[Laboratory tests on the possibility of an oral immunization with a sodium desoxycholate extract of dyspepsia coli strains. V. Group specificity of the protective effect of a bivalent immunization in the active protection test in mice]. Zentralbl Bakteriol Orig (1968) 0.75
Palliative sedation in 2 children with terminal cancer - an effective treatment of last resort in a home care setting. Klin Padiatr (2011) 0.75
[Acute nonlymphatic leukemias in childhood--results of a retrospective study in East Germany 1970 to 1980]. Kinderarztl Prax (1988) 0.75
[Isolated infiltration of the vitreous body as a sign of blast crisis in chronic myeloid leukemia]. Fortschr Ophthalmol (1990) 0.75
[Central nervous system complications arising from respiratory tract infections]. Padiatr Grenzgeb (1974) 0.75
[Acute nonlymphatic leukemia in childhood. Results of the 1st prospective multicenter therapy study AML I/82 in East Germany]. Kinderarztl Prax (1988) 0.75
[Coronary risk factors in chronic hemodialysis patients]. Med Klin (Munich) (1996) 0.75
[Experiences with miconazole in the prevention and therapy of candidiasis]. Padiatr Grenzgeb (1979) 0.75
[Intrathecal radiogold application for meningosis "prophylaxis" in children with leukemias and non-Hodgkin lymphomas. II. Results and problems from viewpoint of nuclear medicine]. Radiobiol Radiother (Berl) (1981) 0.75
[Experimental animal studies with Campylobacter jejuni and Campylobacter coli in chickens]. Arch Exp Veterinarmed (1987) 0.75
[Intrathecal radiogold application for meningosis "prophylaxis" in children with leukemias and non-Hodgkin lymphomas. I. Results and problems from the clinical viewpoint]. Radiobiol Radiother (Berl) (1981) 0.75
[Prevention of central nervous system involvement with intrathecal 198Au colloid and methotrexate in non-Hodgkin lymphoma, acute non-lymphatic leukaemia and Ewing's sarcoma]. Dtsch Med Wochenschr (1982) 0.75
[Lung involvement in lymphogranulomatosis in childhood]. Padiatr Grenzgeb (1983) 0.75
[Purification of staphylococcal enterotoxins A-E]. Z Gesamte Hyg (1979) 0.75
[Lymphogranulomatosis and dermatomyositis]. Padiatr Grenzgeb (1983) 0.75
[Production of diagnostic antisera for the detection of staphylococcal enterotoxins A-E]. Z Gesamte Hyg (1980) 0.75
[Chronic enteral failure to thrive cause by a neuroblastoma]. Padiatr Grenzgeb (1988) 0.75
[The irradiation sequelae in children with lymphogranulomatosis]. Padiatr Grenzgeb (1990) 0.75
[Laboratory experiments on the possibilities of oral immunization with a sodium deoxycholate extract from dyspepsia coli strains. IX. The duration of the achieved protection with this extract in the active protection test in mice]. Zentralbl Bakteriol Orig (1969) 0.75
[Cultivated cells from smooth muscle organs. II. Cultivation of isolated rat aorta cells]. Tsitologiia (1975) 0.75
[Therapeutic study VII/81 of the treatment of acute lymphoblastic leukemia in childhood]. Kinderarztl Prax (1986) 0.75
[Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87]. Klin Padiatr (2001) 0.75
Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987. Haematol Blood Transfus (1990) 0.75
[Experiences with modified BFM protocols in the treatment of children with acute lymphoblastic leukemia (ALL) in East Germany 1981-1991]. Klin Padiatr (1992) 0.75
[Animal experiments with Campylobacter coli using suckling pigs]. Arch Exp Veterinarmed (1988) 0.75
[Treatment of trichuriasis]. Kinderarztl Prax (1968) 0.75
Reaction of facial soft tissues to treatment with a Herbst appliance. J Orofac Orthop (2012) 0.75
[Studies on in vitro cultivated cells of organs with smooth musculature. 4. The contraction relationship of in vitro cultivated cells of the aorta and the urinary bladder of the rat]. Pharmazie (1976) 0.75
[Yersinia enterocolitica infection in childhood]. Kinderarztl Prax (1984) 0.75
[The radiation exposure of the RHS of the liver during intrathecal radio-gold therapy]. Radiobiol Radiother (Berl) (1977) 0.75
[Variety of location and enterotoxin formation by Staphylococcus aureus strains from samples taken from man, cattle and sheep]. Z Gesamte Hyg (1977) 0.75
Interventional pneumology in pulmonary bleeding; a review: from the bronchus to the vessel. Diagn Ther Endosc (1997) 0.75
[Acquired factor XIII deficiency and clinical surgery]. Med Welt (1981) 0.75
[Effect of various therapeutic protocols on growth and final height of children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma]. Klin Padiatr (1996) 0.75
[Varicellas and herpes zoster in children with oncologic diseases. 2: Prevention and therapy]. Z Arztl Fortbild (Jena) (1989) 0.75
Characterization of Campylobacter jejuni and Campylobacter coli isolated from waste water. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.75
Immunity following congenital measles. Scand J Infect Dis (1972) 0.75
[Echovirus infections in a pediatric clinic]. Zentralbl Bakteriol Orig A (1972) 0.75
[Laboratory experiments on the possibilities of oral immunization by means of a sodium desoxycholate extract from dyspepsia coli strains. 8. Serum antibodies the Fragraeus mixed hemadsorption reaction in immunized and challenged mice]. Zentralbl Bakteriol Orig (1969) 0.75
[Leukapheresis for the initial treatment of acute lymphoblastic leukemia in childhood]. Padiatr Grenzgeb (1983) 0.75
[Laboratory studies of the possibility of oral immunization with a sodium desoxycholate extract of dyspepsia coli strains. VII. Serum antibodies in the indirect hemagglutination reaction in immunized and loaded mice]. Zentralbl Bakteriol Orig (1968) 0.75
[Results and experiences with a modified BFM protocol for treatment of recurrences in children with acute lymphoblastic leukemia in East German areas]. Klin Padiatr (1993) 0.75
[Endotracheal silicon stents in therapy management of benign tracheal stenoses]. HNO (2001) 0.75
Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin. Infection (1992) 0.75
[Detection of Campylobacter jejuni and Campylobacter coli in the routine laboratory]. Z Gesamte Hyg (1984) 0.75
[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)]. Klin Padiatr (1999) 0.75
[Distribution of enterotoxinogenic strains among Staphylococcus aureus isolated from various sources]. Zh Mikrobiol Epidemiol Immunobiol (1980) 0.75
Improved treatment results in childhood acute nonlymphoblastic leukemia with the BFM-AML protocol 78 in a multicenter study in the GDR. Haematol Blood Transfus (1987) 0.75
[Therapy of acute myeloid leukemia in children--results of the AML II/87 multicenter study]. Kinderarztl Prax (1991) 0.75
[A simple procedure for microaerophilic culture of Campylobacter in the routine laboratory]. Z Med Lab Diagn (1985) 0.75
[The effect of different ALL therapeutic protocols on body height and the growth rate]. Padiatr Grenzgeb (1990) 0.75
[Some clinical aspects of therapeutic administration of iron preparations in childhood: iron and infections]. Kinderarztl Prax (1991) 0.75
[Transfusion hepatitis following exchange transfusion]. Dtsch Gesundheitsw (1972) 0.75
[Crown preparations]. ZWR (1986) 0.75
[A food-borne infection caused by Campylobacter jejuni serotype Lauwers 19]. Zentralbl Bakteriol Mikrobiol Hyg B (1986) 0.75
[Prophylaxis of dyspepsia coli infection]. Dtsch Gesundheitsw (1968) 0.75
[Leukemic iris infiltration as an isolated recurrence of acute lymphoblastic leukemia]. Padiatr Grenzgeb (1983) 0.75